Longer-Term Safety and Efficacy Measures of AR101 Oral Immunotherapy for Peanut Allergy: Results from a Phase 3 Follow-On Study.

Details

Language :

English

ISSN :

00916749

Volume :

143

Issue :

2

Database :

Supplemental Index

Journal :

Journal of Allergy & Clinical Immunology

Publication Type :

Academic Journal

Accession number :

134743822

Full Text :

https://doi.org/10.1016/j.jaci.2018.12.781